ePharmaSolutions to acquire Polaris BioPharma
Meets demand for more local site feasibility and patient recruitment support on global trials
ePharmaSolutions, a US-based provider of technology based clinical services, has acquired Polaris BioPharma Consulting, for an undisclosed sum.
Polaris BioPharma Consulting is a global patient recruitment and retention firm headquartered in Slough, UK. ePharmaSolutions is headquartered in Philadelphia and also has offices in Slough.
The acquisition increases ePharmaSolutions' global bandwidth while expanding its core workforce with a team of experienced patient recruitment specialists in every major continent who can implement global projects at the local level.
Lance Converse, ePharmaSolutions’ founder and ceo, said: ‘We have worked closely with Polaris over the last ten years on some very complex projects, and they have always delivered.
‘They have a wealth of knowledge of the regulatory, clinical and cultural landscape, from a local perspective, and have connections with varied regional referral sources to expedite study enrolment. This addition is integral to the company's continued growth.’
Polaris Biopharma was founded in 1999 and has grown to 20 local recruitment specialists in every continent providing in-country support on global recruitment campaigns.
Sanjiv Kanwar, md of Polaris BioPharma, said: ‘We can now fully leverage the data-driven technology assets ePharmaSolutions has developed with Polaris' global experience and regionally based recruitment specialists to provide sponsors with high-impact, results-driven site feasibility and patient recruitment campaigns.’
